Cancer genetics: Initially complex, always heterogeneous.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Antitumor effects of dauricine on sorafenib-treated human lung cancer cell lines via modulation of HIF-1α signaling pathways.Medical oncology (Northwood, London, England) · 2025
   Article
2. Drug Conjugates for Targeting Eph Receptors in Glioblastoma.Pharmaceuticals (Basel, Switzerland) · 2020
   Article
3. Robust genetic interaction analysis.Briefings in bioinformatics · 2019
   Review
4. Receptor-Targeted Glial Brain Tumor Therapies.International journal of molecular sciences · 2018
   Review
5. Identifying gene-environment interactions for prognosis using a robust approach.Econometrics and statistics · 2017
   Article
6. Enhancing cancer clonality analysis with integrative genomics.BMC bioinformatics · 2015
   Article
7. Multiclass cancer classification based on gene expression comparison.Statistical applications in genetics and molecular biology · 2014
   Article
8. Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis.BMC bioinformatics · 2014
   Article
9. [Personalized targeted therapy for lung cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2013
   Review
10. Targeted therapies in development for non-small cell lung cancer.Journal of carcinogenesis · 2013
    Review
11. Personalized targeted therapy for lung cancer.International journal of molecular sciences · 2012
    Review
12. Deadly teamwork: neural cancer stem cells and the tumor microenvironment.Cell stem cell · 2011
    Review

Corrections and comments

• Comment on
  Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.